VanA-mediated high level glycopeptide resistance in MRSA
Investigación publicada en The Lancet Infectious Diseases
1 de febrero de 2003
We recently encountered what many consider to be the most important
event of the past 20 years in bacterial antibiotic resistance—namely, the isolation in hospitals in Michigan (July 2002) and Pennsylvania (October 2002) of two distinct meticillinresistant Staphylococcus aureus (MRSA)that are also resistant to high concentrations of vancomycin
Gonzalez-Zorn B. y Courvalin P.
Participantes:
 | Departamento de Sanidad Animal. Facultad de Veterinaria. Universidad Complutense (UCM). |
| Servicio de Zoonosis de Transmisión Alimentaria y Resistencia a Antimicrobianos (ZTA). Centro de Vigilancia Sanitaria Veterinaria (VISAVET). Universidad Complutense (UCM). |
 | Institut Pasteur. |
